Telix Pharmaceuticals | TLX - Pre Tax Profit



Telix Pharmaceuticals reported AUD10.69M in Pre-Tax Profit for its fiscal semester ending in December of 2024.


Pre Tax Profit Change Date
Cochlear AUD 254.2M 6.2M Jun/2024
CSL USD 2.54B 1.34B Dec/2024
Integral Diagnostics AUD 14.49M 47.37M Jun/2024
Mayne Pharma AUD -57610000 20.18M Jun/2024
Medical Developments International AUD -6390000 0 Dec/2023
Mesoblast USD -55506000 22.86M Jun/2024
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge -714000 49K Mar/2024
Polynovo AUD 312K 232K Jun/2024
PYC Therapeutics -25865000 24.72M Dec/2024
Ramsay Health Care AUD 240.1M 24.6M Jun/2024
ResMed USD 458.05M 21.05M Jun/2025
Sonic Healthcare AUD 348.85M 133.56M Dec/2024